WuXi to build €325m biomanufacturing facility in Ireland

WCN Editorial Team 3 May 2018 EUROPE BUSINESS

WuXi Biologics, a Hong Kong-listed open-access biologics technology platform company, will invest €325m in a new biologics drug substance manufacturing facility on the Industrial Development Authority’s (IDA) greenfield site in Mullagharlin, Ireland.

The facility is expected to create 400 new jobs over five years.

WuXi Biologics, based in Wuxi city, Jiangsu province, China, provides end-to-end solutions for biologics.

The modern facility will be built upon the approach WuXi Biologics has pioneered, deploying multiple single-use bioreactors for commercial biomanufacturing.

It will also be designed to run continuous bioprocessing, a next generation manufacturing technology that will be first implemented globally in this campus.

The facility will have 48,000 L fed-batch and 6,000 L perfusion bioreactor capacity – the world’s largest facility using single-use bioreactors.

To be established on a 26-hectare campus, the manufacturing project will be the company’s first site outside China. The Irish government is supporting the project through IDA Ireland.

Ireland Prime Minister An Taoiseach Leo Varadkar said in Dundalk: “This is the start of something special. We will see the Factory of the Future, right here in Dundalk.

“It’s the first sizable greenfield project from China in the pharma sector and I am delighted to see it located here in Dundalk.

“It’s also the latest in a number of investments in this town which has become a hub for a range of sectors, mainly in the new knowledge-based and pharmaceutical sectors.”

Minister for Business, Enterprise & Innovation Heather Humphreys TD said: “This huge €325m investment is a great vote of confidence in Ireland and reinforces our image as a global centre of excellence in Biologics.”

WuXi Biologics chairman Ge Li said: “We have been engaging IDA and Ireland Strategic Investment Fund (ISIF) for several years before finalising today’s exciting investment in this community.

“This is our second major partnership in Ireland, following WuXi NextCODE’s work with Genomics Medicine Ireland (GMI).”

With 11 websites and newsletters covering all the key areas within the construction industry, World Construction Industry Network is the leading global construction information resource. READ ABOUT US



World Construction Network | www.worldconstructionnetwork.com is a product of GlobalData. Copyright © 2021 GlobalData. All rights reserved.